RET and medullary thyroid gland carcinoma: A recent investigation using the Examination Aggregation Consortium (ExAC) dataset estimated the penetrance of medullary thyroid carcinoma to be approximately 4% among RET variant (c.2410G > A), (p.Val804Met) carriers [38].